Drugmaker Stocks Slide as Trump Taps Vaccine Skeptic RFK Jr for US Health Job
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy Jr., who has previously spread misinformation on vaccines, to lead the Department of Health and Human Services (HHS).
Despite the uncertainty introduced by the nomination of Robert F Kennedy Jr., an outspoken vaccine skeptic, as the potential HHS ... Ahmad covers the Healthcare sector, focusing on stocks such as ...
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
Key Takeaways Vaccine maker stocks fell in Friday morning trading after president-elect Donald Trump said he would nominate ...
U.S. stocks suffered their worst loss since election day as the boost from Donald Trump's victory and a Federal Reserve ...
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid ...
Robert F. Kennedy could face some resistance as he tries to get confirmed by the Senate to be President-elect Trump's Secretary of Health and Human Services. Kennedy has said that he hopes to overhaul ...
If confirmed, Robert F. Kennedy Jr. will have broad influence over federal agencies and health care policy — a prospect that worries many in public health given his history of conspiracy theories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback